Technology | June 04, 2013

Siemens Offers New MR Breath-Holding Software

CAIPIRINHA reduces patient MR breath-hold up to 50 percent without sacrificing image resolution

June 4, 2013 — Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) recently cleared the company’s CAIPIRINHA (Controlled Aliasing in Volumetric Parallel Imaging Results IN Higher Acceleration) software as part of Siemens’ syngo MR D13A software package for parallel magnetic resonance imaging (MRI). The MRI software helps enable patients with breath-holding difficulties to reduce the amount of time they hold their breath by up to 50 percent without sacrificing imaging resolution or contrast.

Siemens’ CAIPIRINHA software enables acquisition of higher-quality 3-D volumetric interpolated breath-hold sequence (VIBE) T1 images through higher acceleration factors. factors. CAIPIRINHA software is included as standard with Siemens’ D13A software for MAGNETOM Aera 1.5 Tesla, Magnetom Skyra 3.0T, Magnetom Avanto 1.5T, and Magnetom Verio 3.0T systems. It is also available with Siemens’ D14 software for the Magnetom Essenza 1.5T system.

For more information: www.siemens.com/healthcare

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...